Home AbbVie Announces CEO Transition: Robert A. Michael to Succeed Richard A. Gonzalez Effective July 1, 2024

AbbVie Announces CEO Transition: Robert A. Michael to Succeed Richard A. Gonzalez Effective July 1, 2024

Feb 21, 2024 07:48 CST Updated 07:49
AbbVie

Innovative Drug Developer